Wednesday, June 29, 2011

Biogen has a lot going for it

Complete article

I screened on Barchart for the S&P 100 companies having the most frequent new highs and Biogen Idec (BIIB) had 9 new highs and is up 15.33% in just the last month.  The company has a very, very nice balance sheet with 1.2 billion in cash and a debt to capital ratio of only 16%.  It has began to repurchase stock and will have cash to buy into new products.  Carl Ichan is one of the major stock holders so a buy out take over can't be ignored.  I'm looking at the stock momentum.

Barchart technical indicators:
  • 100% Barchart technical buy signal
  • Trend Spotter buy signal
  • Above its 20, 50 and 100 day moving averages
  • 9 new highs and up 15.33% in the last month
  • Relative Strength Index 77.87% and rising
  • Trades around 107.74 with a 50 day moving average of 96.03

    Summary:  Biogen Indec (BIIB) has momentum with 9 new highs and up 15.33% in the last month, an extremely conservative balance sheet and analysts looking for increases in earnings over the next 5 years.

    Jim Van Meerten is a Marketocracy Master

    No comments:

    Post a Comment